Cargando…
The impact of zero markup drug policy on patients' healthcare utilization and expense: An interrupted time series study
OBJECTIVE: To curb the unreasonable growth of pharmaceutical expenditures, Beijing implemented the zero markup drug policy (ZMDP) in public hospitals in 2017, which focused on separating drug sales from hospital revenue. The purpose of this study is to evaluate the impacts of ZMDP on healthcare expe...
Autores principales: | Zhu, Zheng, Wang, Junfeng, Sun, Yan, Zhang, Jiawei, Han, Peien, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705579/ https://www.ncbi.nlm.nih.gov/pubmed/36457568 http://dx.doi.org/10.3389/fmed.2022.928690 |
Ejemplares similares
-
Systematic Review of the Effect of a Zero-Markup Policy for Essential Drugs on Healthcare Costs and Utilization in China, 2015–2021
por: Liu, Wen-Yi, et al.
Publicado: (2021) -
The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis
por: Wang, Ruilin, et al.
Publicado: (2023) -
The Impact of China’s Zero Markup Drug Policy on Hospitalization Expenses for Inpatients in Tertiary Public Hospitals: Evidence Based on Quantile Difference-in-Difference Models
por: Ni, Ziling, et al.
Publicado: (2021) -
Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis
por: Wang, Junman, et al.
Publicado: (2020) -
Did the universal zero-markup drug policy lower healthcare expenditures? Evidence from Changde, China
por: Peng, Zixuan, et al.
Publicado: (2021)